NCT00748891View on ClinicalTrials.gov

DCE CT/MRI Scanning Study in Patients With Solid Tumours (AstraZeneca and Royal Marsden Hospital Imaging Study)

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 31, 2008

Primary Completion Date

February 28, 2010

Study Completion Date

November 30, 2010

Conditions
Cancer
Interventions
DRUG

Recentin (Cediranib)

30mg once daily, oral dose

Trial Locations (1)

Unknown

Research Site, London

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
collaborator

Royal Marsden NHS Foundation Trust

OTHER

lead

AstraZeneca

INDUSTRY